What is the typical time interval between absent diastolic flow and reversed end-diastolic flow in the umbilical artery (UA) of a growth-restricted fetus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Time Interval Between Absent and Reversed End-Diastolic Flow in Growth-Restricted Fetuses

The progression from absent end-diastolic flow (AEDV) to reversed end-diastolic flow (REDV) in growth-restricted fetuses is unpredictable and can occur rapidly, necessitating Doppler assessment 2-3 times per week once AEDV is detected due to the potential for deterioration within days. 1

Evidence on Progression Timeline

The available evidence does not establish a specific, predictable time interval between AEDV and REDV. However, the clinical data reveals important patterns:

  • Rapid deterioration is possible within the first 2 weeks after diagnosis of FGR, with the most critical period for progression occurring early after abnormal Doppler findings emerge 1

  • Historical observational data from 1991 showed that reverse flow was observed after a mean delay of approximately 6-8 days in high-risk IUGR cases, though this represents older data with different management protocols 2, 3

  • The progression is sufficiently unpredictable that current guidelines mandate increased surveillance frequency (2-3 times weekly) once AEDV is detected, rather than relying on a specific time interval 1

Clinical Implications for Surveillance

The lack of a predictable timeline is precisely why surveillance intensity must escalate immediately upon detecting AEDV:

  • Weekly umbilical artery Doppler is recommended for decreased end-diastolic velocity or severe FGR (EFW <3rd percentile) 1

  • Doppler assessment must increase to 2-3 times per week when AEDV is detected due to the potential for rapid deterioration to REDV 1

  • Hospital admission should be considered if fetal surveillance more than 3 times per week is deemed necessary 1, 4

Severity Distinction and Management

The distinction between AEDV and REDV carries critical prognostic and management implications:

  • REDV represents a more severe stage of placental compromise with significantly worse outcomes, including perinatal mortality rates of 46% in historical series compared to 20% with AEDV 1

  • REDV mandates immediate hospitalization, antenatal corticosteroids, heightened surveillance with cardiotocography at least 1-2 times daily, and consideration of delivery 1, 5

  • Delivery timing differs substantially: AEDV warrants delivery at 33-34 weeks, while REDV warrants delivery at 30-32 weeks 4, 5, 6

Research Evidence on Progression Patterns

Recent studies provide additional context on deterioration patterns:

  • In a 2022 study, progression to REDV occurred in 7.9% of cases with intermittent AEDV versus 25.6% with persistent AEDV, suggesting that the pattern of AEDV (intermittent vs persistent) influences progression risk 7

  • A 2024 study found that with normal Doppler indices, significant deterioration to AEDV/REDV is unlikely until 4 weeks after FGR diagnosis, but once abnormal indices appear, progression can be more rapid 8

Critical Clinical Pitfalls

  • Do not assume a predictable timeline exists - the progression from AEDV to REDV can occur within days and requires intensive monitoring 1

  • Distinguish between intermittent and persistent AEDV (<50% vs ≥50% of cardiac cycles), as persistent AEDV carries higher risk of progression to REDV 7

  • Earlier gestational age at FGR diagnosis and chronic hypertension are risk factors for more rapid Doppler deterioration 8

  • Once REDV develops, do not delay delivery - this represents extreme placental insufficiency with high perinatal mortality risk 1, 5, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 1991

Guideline

Management of Two-Vessel Umbilical Cord in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of SGA Fetus with Reversed End-Diastolic Flow

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Fetal Growth Restriction with High Resistance Umbilical Artery Doppler

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best course of action for a pregnant patient at 35 weeks of gestation with severe fetal growth restriction and absent end-diastolic flow on umbilical artery Doppler?
What is the best course of action for a primigravida (first-time pregnant woman) at 37 weeks gestation with severe hypertension, fetal growth restriction, and absent end diastolic flow?
What is the best course of action for a fetus with reversed end-diastolic flow on umbilical artery Doppler?
What is the most appropriate management for a patient at 33 weeks' gestation with a small for gestational age (SGA) fetus and reversed end-diastolic flow on umbilical artery Doppler?
What is the best course of action for a 30-something year old primigravida (first-time pregnant woman) at 37 weeks gestational age (GA) with severe hypertension, irritated on examination, and absent end diastolic flow?
What is the recommended duration for Plavix (clopidogrel) washout before surgery to minimize the risk of bleeding in a patient taking the medication?
Could hair loss in a lifelong weight trainer with poor diet and no aerobic exercise be due to a condition other than peripheral arterial disease (PAD) or atherosclerosis?
What is the recommended first-level analysis for a patient suspected of having celiac disease, considering potential IgA deficiency and impaired renal function?
What is the recommended duration for taking Imdur (isosorbide mononitrate) after angioplasty in a patient with a history of angina or other cardiac conditions?
What is the correct way to describe a hernia in terms of its location, size, and reducibility for determining the appropriate management strategy?
Which antibiotic, azithromycin or Rocephin (ceftriaxone), provides better coverage for a blood culture with Gram-positive cocci in clusters in the aerobic bottle, suggestive of Staphylococcus aureus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.